Rights and permissions
About this article
Cite this article
Carboplatin plus etoposide vs supportive care alone in NSCLC. Pharmacoecon. Outcomes News 172, 10 (1998). https://doi.org/10.1007/BF03277687
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277687